These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 18997792)
1. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792 [TBL] [Abstract][Full Text] [Related]
2. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794 [TBL] [Abstract][Full Text] [Related]
3. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling. Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394 [TBL] [Abstract][Full Text] [Related]
4. Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Yang XD; Sun SC Immunol Rev; 2015 Jul; 266(1):56-71. PubMed ID: 26085207 [TBL] [Abstract][Full Text] [Related]
5. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation. Song YJ; Kang MS Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848 [TBL] [Abstract][Full Text] [Related]
6. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Gardam S; Sierro F; Basten A; Mackay F; Brink R Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334 [TBL] [Abstract][Full Text] [Related]
7. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096 [TBL] [Abstract][Full Text] [Related]
8. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983 [TBL] [Abstract][Full Text] [Related]
9. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells. Michel M; Wilhelmi I; Schultz AS; Preussner M; Heyd F J Biol Chem; 2014 May; 289(19):13651-60. PubMed ID: 24671418 [TBL] [Abstract][Full Text] [Related]
13. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805 [TBL] [Abstract][Full Text] [Related]
14. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2. Kim JY; Morgan M; Kim DG; Lee JY; Bai L; Lin Y; Liu ZG; Kim YS J Cell Sci; 2011 Feb; 124(Pt 4):647-56. PubMed ID: 21266470 [TBL] [Abstract][Full Text] [Related]
15. Involvement of A20 in the molecular switch that activates the non-canonical NF-кB pathway. Yamaguchi N; Oyama M; Kozuka-Hata H; Inoue J Sci Rep; 2013; 3():2568. PubMed ID: 24008839 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1). Lee S; Challa-Malladi M; Bratton SB; Wright CW J Biol Chem; 2014 Oct; 289(44):30680-30689. PubMed ID: 25246529 [TBL] [Abstract][Full Text] [Related]
17. Non-canonical NF-κB signaling activation and regulation: principles and perspectives. Razani B; Reichardt AD; Cheng G Immunol Rev; 2011 Nov; 244(1):44-54. PubMed ID: 22017430 [TBL] [Abstract][Full Text] [Related]
18. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868 [TBL] [Abstract][Full Text] [Related]
19. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. McPherson AJ; Snell LM; Mak TW; Watts TH J Biol Chem; 2012 Jun; 287(27):23010-9. PubMed ID: 22570473 [TBL] [Abstract][Full Text] [Related]
20. XEDAR activates the non-canonical NF-κB pathway. Verhelst K; Gardam S; Borghi A; Kreike M; Carpentier I; Beyaert R Biochem Biophys Res Commun; 2015 Sep; 465(2):275-80. PubMed ID: 26260321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]